Previous 10 | Next 10 |
ALPHARETTA, Ga., April 02, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that Daniel H. White, President and Chief ...
The following slide deck was published by Clearside Biomedical, Inc. in conjunction with this Read more ...
Clearside Biomedical, Inc. (CLSD) Q4 2018 Earnings Conference Call March 12, 2019 5:00 PM ET Company Participants Jenny Kobin - Investor Relations Daniel White - President & Chief Executive Officer Thomas Ciulla - Chief Medical Officer Brion Raymond - Chief Commercial Offic...
Clearside Biomedical (NASDAQ: CLSD ): Q4 GAAP EPS of -$0.68 misses by $0.11 . More news on: Clearside Biomedical, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
- Novel Retinal Treatment Demonstrates Potential of Proprietary Therapeutic Platform - - XIPERE ™ NDA Accepted and On Track for October 19, 2019 PDUFA Date - - Management to Host Webcast and Conference Call Today at 5:00 PM ET - ALPHARETTA, Ga., March 12, 2019 (GLOBE NEWSWIR...
ALPHARETTA, Ga., March 04, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that Daniel H. White, President and Chief ...
ALPHARETTA, Ga., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that its fourth quarter and year end 2018 f...
CORAL GABLES, FL / ACCESSWIRE / February 20, 2019 / The tech stock market is built upon the ideals of an industry which is constantly changing. It is the very nature of technology that if devices serve their purpose for long enough, we will learn to live without them through adaptation, so...
Gainers: Kandi Technologies Group (NASDAQ: KNDI ) +47% . LeMaitre Vascular (NASDAQ: LMAT ) +28% . AzurRx BioPharma (NASDAQ: AZRX ) +29% . Blink Charging (NASDAQ: BLNK ) +21% . Carrols Restaurant Group (NASDAQ: TAST ) +17% . OneSpan (NASDAQ: OSPN ) +17% . Garmin (NASDAQ: GRMN ) ...
Kandi Technologies (NASDAQ: KNDI ) +28% as NHTSA approves two pure electric vehicle models. More news on: Kandi Technologies Group, Inc., BioSig Technologies, Inc., OneSpan Inc, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
ALPHARETTA, Ga., July 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), has opened registration for its virtual key opinion l...
ALPHARETTA, Ga., July 11, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today the appointment of Glenn C. Yiu, M.D....
- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachoroidal Drug Delivery - - Target Profile for CLS-AX in Wet AMD Landscape and Potential Opportunities for Clearside Pipeline Expansion - ...